Sit Investment Associates Inc. Sells 23,560 Shares of Tenet Healthcare Corporation $THC

Sit Investment Associates Inc. lowered its position in Tenet Healthcare Corporation (NYSE:THC) by 51.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 22,065 shares of the company’s stock after selling 23,560 shares during the period. Sit Investment Associates Inc.’s holdings in Tenet Healthcare were worth $4,385,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in THC. Triumph Capital Management purchased a new position in shares of Tenet Healthcare during the 3rd quarter worth $25,000. Activest Wealth Management bought a new position in shares of Tenet Healthcare during the fourth quarter worth $26,000. Elyxium Wealth LLC purchased a new position in shares of Tenet Healthcare during the fourth quarter valued at about $29,000. Meeder Asset Management Inc. grew its holdings in Tenet Healthcare by 146.2% during the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock valued at $38,000 after buying an additional 114 shares in the last quarter. Finally, Canada Pension Plan Investment Board bought a new stake in Tenet Healthcare in the second quarter worth $35,000. 95.44% of the stock is currently owned by institutional investors.

Tenet Healthcare Price Performance

NYSE THC opened at $172.63 on Friday. Tenet Healthcare Corporation has a 1 year low of $146.60 and a 1 year high of $247.21. The company has a market cap of $14.87 billion, a price-to-earnings ratio of 8.98, a PEG ratio of 1.42 and a beta of 1.28. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. The stock’s fifty day moving average price is $182.44 and its 200 day moving average price is $198.55.

Tenet Healthcare (NYSE:THC) last released its earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The firm had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.39 billion. During the same quarter in the previous year, the company posted $4.36 earnings per share. The company’s revenue was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, equities research analysts forecast that Tenet Healthcare Corporation will post 17.61 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts recently commented on THC shares. Leerink Partners lifted their price target on Tenet Healthcare from $255.00 to $264.00 and gave the stock an “outperform” rating in a research report on Friday, February 20th. Weiss Ratings cut shares of Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 2nd. Morgan Stanley set a $254.00 price objective on Tenet Healthcare in a report on Friday, May 1st. Mizuho boosted their price target on shares of Tenet Healthcare from $235.00 to $265.00 and gave the company an “outperform” rating in a report on Thursday, March 12th. Finally, Cantor Fitzgerald restated an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. Eighteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, Tenet Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $244.16.

Insider Transactions at Tenet Healthcare

In other news, Director J Robert Kerrey sold 5,638 shares of the business’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the transaction, the director owned 16,804 shares of the company’s stock, valued at $2,932,634.08. The trade was a 25.12% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Nadja West sold 3,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total value of $532,050.00. Following the completion of the transaction, the director directly owned 24,805 shares of the company’s stock, valued at $4,399,166.75. The trade was a 10.79% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.97% of the company’s stock.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.